(3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

C29H51NO — CID 175019555

IUPAC(3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILESCC(CCCN)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C29H51NO/c1-20(8-6-18-30)7-5-9-21(2)25-12-13-26-24-11-10-22-19-23(31)14-16-28(22,3)27(24)15-17-29(25,26)4/h10,20-21,23-27,31H,5-9,11-19,30H2,1-4H3/t20?,21?,23-,24-,25+,26-,27-,28-,29+/m0/s1
InChIKeyZLGJBAYMEDCNJM-UWKHYISVSA-N
MW429.73 g/mol
LogP7.11
Rot. Bonds8

About (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (PubChem CID 175019555) has the molecular formula C29H51NO and a molecular weight of 429.73 g/mol. Its IUPAC name is (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.

Molecular Properties

Compound Name(3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
PubChem CID175019555
Molecular FormulaC29H51NO
Molecular Weight429.73 g/mol
Exact Mass429.40
IUPAC Name(3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILESCC(CCCN)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C29H51NO/c1-20(8-6-18-30)7-5-9-21(2)25-12-13-26-24-11-10-22-19-23(31)14-16-28(22,3)27(24)15-17-29(25,26)4/h10,20-21,23-27,31H,5-9,11-19,30H2,1-4H3/t20?,21?,23-,24-,25+,26-,27-,28-,29+/m0/s1
InChIKeyZLGJBAYMEDCNJM-UWKHYISVSA-N
XLogP7.11
TPSA46.25 Ų
H-Bond Donors2
H-Bond Acceptors2
Rotatable Bonds8
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500429.73
LogP ≤ 57.11
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The IUPAC name of (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (CID 175019555) is (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.
What is the SMILES notation for (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The canonical SMILES for (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol is CC(CCCN)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The InChIKey is ZLGJBAYMEDCNJM-UWKHYISVSA-N. The full InChI is InChI=1S/C29H51NO/c1-20(8-6-18-30)7-5-9-21(2)25-12-13-26-24-11-10-22-19-23(31)14-16-28(22,3)27(24)15-17-29(25,26)4/h10,20-21,23-27,31H,5-9,11-19,30H2,1-4H3/t20?,21?,23-,24-,25+,26-,27-,28-,29+/m0/s1.
What are the key properties of (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
(3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol has a molecular weight of 429.73 g/mol, XLogP of 7.11, 8 rotatable bonds, 2 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,8S,9S,10R,13R,14S,17R)-17-(9-amino-6-methylnonan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol is sourced from PubChem (CID 175019555), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).